2Montaho G, Cervello M, Giannitrapani L, et al. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci,2002,963(6) : 13 - 20
4Sangiovanni A, Colombo E, Radaelli F, et al. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients. Am J Gastroenterol,2001,96(5) : 1575 - 1580
5Donato MF, Arosio E, Monti V, et al. Proliferating cell nuclear antigen assessed by a computer-assisted image analysis system in patients with chronic viral hepatitis and cirrhosis. Dig Liver Dis, 2002,34 (3): 197-203
6Donato MF,Amsio E,Ninno ED, et al. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology, 2001,34 (3) : 523 -528
7Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol, 2003,38 Suppl 1 : S136 - 49
7Su Q, Bonnet A, Hofmann WJ et al .Human hepatic preneoplasia:phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch, 1997,431:391.
8Watanabe S, Okita K, Harada T et al . Morphologic studies of the liver cell dysplasia. Cancer, 1983,51:2197.
9Lemire JM, Shiojiri N, Fausto Net al . Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D galactosamine. Am J Pathol, 1991,139:535.
10Su Q,Liu YF,Zlumg JF et al . Expression of insulin-like growth factor Ⅱ in hepatitis B,cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology, 1994, 20:788.
